A liberal transfusion strategy following major vascular or general surgery did not significantly improve outcomes at 90 days post procedure in patients at high risk of a cardiac event when compared to ...
New late-breaking science presented at AHA 2025 in New Orleans highlights new treatments for patients with severe hypertriglyceridemia (500-2,000 mg/dL), who may be at high risk of cardiovascular ...
We are a young, vibrant section dedicated to adding value to Section members interested in Innovation across the cardiovascular spectrum. Our section is member-driven and focused on all aspects of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback